WuXi AppTec (English); 药明康德（中文）
WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform company with global operations. As an innovation-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of services to help our worldwide customers and partners shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient solutions. With its industry-leading capabilities in small molecule R&D and manufacturing, biologics R&D and manufacturing, cell therapy and gene therapy R&D and manufacturing, medical device testing, and molecular testing and genomics, WuXi platform is enabling nearly 3,000 innovative collaborators from more than 30 countries to bring innovative healthcare products to patients, and to fulfill WuXi's dream that "every drug can be made and every disease can be treated."
Dr. Ge Li, Chairman and Chief Executive Office
Our vision is to become the most comprehensive capability and technology platform in the global pharmaceutical and healthcare industry to fulfillthe dream that “every drug can be made and every disease can be treated”.
Small Molecule R&D and Manufacturing
Biologics R&D and Manufacturing
Cell Therapy & Gene Therapy
Medical Device Testing
Genomics and Molecular Diagnostics
Number of Customers
Over 3,000 customers & partners globally
26 sites, 6 million square feet worldwide
St. Paul, MN
San Diego, CA
Fields with * are required.